Quick answer: what is GHK-Cu?
GHK-Cu is a naturally occurring copper-binding tripeptide (glycine-histidine-lysine + copper) that declines with age.
New to peptides? Start with what are peptides? and how do peptides work?
Quick facts
- Class
- Copper-binding tripeptide (Gly-His-Lys + Cu²⁺)
- Found in
- Human plasma, saliva, urine (declines with age)
- Studied for
- Skin remodeling, wound healing, hair, antioxidant signaling
- Common use
- Topical cosmetic ingredient (widely sold)
- Evidence level
- Lab + topical human cosmetic studies
- Sequence
- Gly-His-Lys + Cu²⁺
- Found in
- Human plasma, saliva, urine (falls with age)
- INCI name (on labels)
- Copper Tripeptide-1
- Best evidence
- Topical cosmetic / wound-healing studies
- Common use
- Skincare serums and creams
Key takeaways
- Its strongest, most reproducible evidence is topical/cosmetic — skin firmness, fine lines, and wound repair.
- In lab studies it shifts the expression of many genes toward a younger, repair-oriented profile.
- Topical GHK-Cu is a widely permitted cosmetic ingredient; injectable 'research' GHK-Cu is a different, unregulated category.
- It is best thought of as a skin and tissue-signaling peptide, not a systemic drug.
Overview
GHK-Cu is a copper tripeptide, meaning it is a small chain of three amino acids (glycine, histidine, and lysine) bound to a copper ion. It occurs naturally in human plasma, saliva, and urine, and its concentration in the body tends to decline with age, a fact often cited to explain interest in it as a restorative compound.
The peptide has two very different lives. As a topical cosmetic ingredient, GHK-Cu appears in serums and creams marketed for skin firmness, fine lines, and wound support, and this is where its evidence is strongest. Separately, it is sold as an injectable research peptide, a form that is unregulated and far less studied.
This distinction is central to understanding GHK-Cu honestly. The cosmetic story and the injectable story should not be blurred together, because the safety data, regulatory standing, and quality of evidence differ substantially between them.
How it works
GHK-Cu is thought to act partly as a carrier for copper, a trace mineral involved in many enzymatic processes, including those that build and remodel skin structures. By delivering copper to tissues, the peptide may influence wound healing and the turnover of skin components.
Laboratory research has reported that GHK-Cu can affect gene expression, appearing to shift the activity of a broad range of genes in directions associated with tissue repair and reduced inflammation. It has also been studied for stimulating collagen and other extracellular matrix proteins that give skin its firmness and elasticity.
These mechanisms are plausible and supported by cell and tissue studies, but their relevance depends heavily on how the peptide is delivered. A topical formulation acting on skin is a very different scenario from a systemic injection, and the cellular findings do not automatically translate into safe or predictable whole-body effects.
Research & evidence
The most credible evidence for GHK-Cu comes from topical and cosmetic research. Studies and manufacturer-sponsored investigations have reported improvements in skin firmness, density, fine lines, and clarity, along with supportive roles in wound healing. These findings have made GHK-Cu a recognized ingredient in dermatological skincare.
That said, much of this research involves small studies, cosmetic endpoints, or industry funding, so conclusions should be read as encouraging rather than definitive. The peptide's role in wound repair is among its better-documented properties, reflecting decades of interest in copper peptides for skin.
Evidence for injectable GHK-Cu is far weaker. There is little rigorous human clinical data supporting systemic injection for anti-aging or other claimed benefits. Marketing for the injectable form often relies on extrapolation from topical and laboratory studies, which is not a sound basis for assuming the same benefits or safety apply when the compound is injected.
Safety & legal status
As a topical cosmetic ingredient, GHK-Cu is generally considered well tolerated, with occasional skin irritation reported. It is legally available in skincare products in many markets, where it is regulated as a cosmetic rather than a drug.
The injectable form is a different matter. It is not an approved medicine, and products sold for research use are not manufactured or tested to pharmaceutical standards. Risks include contamination, inaccurate dosing, and the general hazards of injecting an unregulated substance. Copper itself can be harmful in excess, which adds a specific concern to systemic use that does not apply to small topical amounts.
Legally, GHK-Cu sits on both sides of a line: a permitted cosmetic ingredient on one hand, and an unregulated research chemical on the other when sold as an injectable. Consumers should treat skincare and injectable products as entirely separate categories, and anyone considering injection should recognize they are using a product without regulatory oversight or established human safety data.
How good is the evidence, really?
GHK-Cu occupies an unusual middle position: better studied than most compounds on this site, but held to a lower evidentiary standard than a medicine, and consistently oversold.
What is genuinely established
The biology is real and not in dispute. GHK is a naturally occurring tripeptide found in human plasma, its concentration declines with age, and it binds copper — a cofactor for enzymes involved in collagen cross-linking and antioxidant defence. Laboratory work on its effects on gene expression and wound-healing pathways is substantial, and it has the deepest research literature of anything in the cosmetic peptide category.
Where the evidence thins
Cell culture is not skin. A large share of the impressive findings come from cells in a dish, where the peptide is applied directly to its target with no barrier in the way. Human skin is specifically built to keep such molecules out.
Cosmetic studies use softer endpoints. Products are regulated as cosmetics, so claims about appearance do not require the evidence a drug would. Typical studies are small, short, sometimes manufacturer-run, and measure appearance rather than tissue change.
Formulation may matter more than the ingredient. Concentration, pH, vehicle and what else is in the bottle all affect how much peptide reaches living skin. Two products listing the same ingredient can behave quite differently, and labels rarely disclose enough to tell.
The fair summary: a real molecule with real biology and a plausible mechanism, supporting modest and gradual cosmetic improvement — not the transformation the marketing implies, and not comparable to a prescription retinoid.
Why copper peptides are handled the way they are
GHK-Cu presents a formulation problem that explains a lot of what you see on shelves.
The copper is not optional. The peptide's activity depends on the copper ion it carries; GHK without copper is a different proposition. That bound copper is also what gives copper-peptide serums their characteristic blue tint — the colour is the ingredient, not a dye.
It is chemically fussy. The complex is sensitive to pH, and copper can interact with other actives. This is the reason formulators often advise against layering copper peptides with strong acids or high-dose vitamin C in the same application — not folklore, but a real chemical interaction that can disrupt the complex.
Peptides degrade in water. Peptide bonds hydrolyse over time in aqueous solution, which is why peptide raw materials are typically supplied freeze-dried and why finished products have meaningful shelf lives, are often packaged in opaque or airless containers, and lose potency with heat and light exposure.
None of this is handling advice — it is why the products are built and packaged as they are, and why a bargain copper-peptide serum of unknown age is a weaker proposition than the ingredient list suggests.
The cosmetic peptides compared
Topical cosmetic peptides fall into distinct functional groups, and they are not interchangeable — one tells skin to build collagen, another delivers a mineral, another interferes with the nerve signalling behind expression lines.
| Matrixyl | GHK-Cu | Argireline | SNAP-8 | |
|---|---|---|---|---|
| Type | Signal peptide (matrikine) | Carrier peptide | Neurotransmitter-inhibiting | Neurotransmitter-inhibiting |
| INCI-style name | Palmitoyl pentapeptide-4 | Copper tripeptide-1 | Acetyl hexapeptide-8 | Acetyl octapeptide-3 |
| Target | Cues collagen and matrix production | Delivers copper, a cofactor for repair enzymes | SNARE proteins at the neuromuscular junction | SNARE proteins, longer sequence |
| Aims at | Fine lines, firmness | Firmness, tone, repair | Expression lines | Expression lines |
| Evidence | Among the better-studied cosmetic peptides | Deepest research literature in the category | Cosmetic studies; effect far smaller than injectables | Marketed as an improved Argireline; less independent data |
| Regulated as | Cosmetic | Cosmetic | Cosmetic | Cosmetic |
Frequently asked questions
What is GHK-Cu?
GHK-Cu is a naturally occurring copper-binding tripeptide — three amino acids (glycine, histidine, and lysine) bound to a copper ion. It is found in human blood, saliva, and urine, where its levels fall with age, and it is best known as a skin-repair and anti-aging ingredient in cosmetics.
What does GHK-Cu stand for or mean?
The letters are the one-letter codes for its three amino acids — Glycine (G), Histidine (H), and Lysine (K) — and Cu is the chemical symbol for copper. So GHK-Cu literally means the glycyl-histidyl-lysine peptide complexed with copper. It's sometimes written GHK-copper or copper tripeptide-1.
Is GHK-Cu safe to use on skin?
Topical GHK-Cu is generally well tolerated and is a permitted cosmetic ingredient in many markets. As with any active, patch-testing is sensible.
Does GHK-Cu really work for wrinkles?
Cosmetic studies report improvements in skin firmness, density, and the appearance of fine lines with regular topical use. It is often compared to a gentler alternative or complement to retinoids.
Is injectable GHK-Cu the same as the skincare ingredient?
No. The robust evidence is for topical/cosmetic use. Injectable 'research' GHK-Cu is unregulated, has limited human safety data, and raises theoretical concerns about excess copper exposure.
What does the copper do?
GHK acts as a carrier for copper, a cofactor for enzymes involved in skin remodeling and antioxidant defense. The peptide and the copper work together.
What is the INCI name for GHK-Cu?
On a cosmetic ingredient list GHK-Cu appears as Copper Tripeptide-1. INCI is the standardised naming system used on product labels, so a serum containing GHK-Cu will usually not print "GHK-Cu" in the ingredients at all — look for Copper Tripeptide-1.
What are the "GHK-Cu uglies"?
A skincare-community term for a temporary period of irritation, dryness or breakouts some people report when starting a copper peptide product. It is anecdotal rather than a documented clinical phenomenon, and irritation on starting any active ingredient can also simply mean the product does not suit your skin.
Can GHK-Cu cause copper toxicity?
Copper toxicity from topical cosmetic use has not been an established problem — the amounts involved are small and absorption through intact skin is limited. Systemic copper overload is a genuine medical condition, but it is associated with metabolic disorders such as Wilson's disease and with excessive oral intake, not with copper peptide serums.
References
Each source links to its original record — peer-reviewed studies, regulator pages, or reference texts, labelled by type. We summarize findings neutrally; a citation is a reference, not an endorsement, and not a claim that its authors reviewed this page.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. Peer-reviewed study
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015. Peer-reviewed study
- Pickart L, Vasquez-Soltero JM, Margolina A. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging. Oxid Med Cell Longev. 2012. Peer-reviewed study
- Ogórek K, Nowak K, Wadych E, et al. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?. Molecules. 2025. Peer-reviewed study
- Dymek M, Olechowska K, Hąc-Wydro K, et al. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application. Pharmaceutics. 2023. Peer-reviewed study
- Sahu R, Yadav S, Gunturu KC, et al. Phenothiazine-Based Cu(II)-Selective Fluorescent Sensor: GHK-Cu Sensing Applications. J Org Chem. 2023. Peer-reviewed study
GHK-Cu in reference databases: Wikipedia · Wikidata · DrugBank · PubChem